Astrazeneca (NASDAQ: AZN) reported Q2 2022 earnings per share (EPS) of $0.12, up 45.24% year over year. Total Astrazeneca earnings for the quarter were $360.00 million. In the same quarter last year, Astrazeneca's earnings per share (EPS) was $0.21.
As of Q4 2022, Astrazeneca's earnings has grown year over year. Astrazeneca's earnings in the past year totalled -$1.25 billion.
What was AZN's revenue last quarter?
Astrazeneca (NASDAQ: AZN) reported Q2 2022 revenue of $10.77 billion up 31.03% year over year. In the same quarter last year, Astrazeneca's revenue was $8.22 billion.
What was AZN's revenue growth in the past year?
As of Q4 2022, Astrazeneca's revenue has grown 49.14% year over year. This is 29.87 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 19.27%. Astrazeneca's revenue in the past year totalled $44.04 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.